Ulrich Wandschneider

Professional at Trilantic Capital Management LP

Ulrich Wandschneider

Ulrich Wandschneider

Professional at Trilantic Capital Management LP

Overview
Career Highlights

MediClin AG
Asklepios Kliniken Hamburg GmbH
Broermann Holding GmbH

RelSci Relationships

203

Number of Boards

15

Birthday

03/1961

Age

58

Relationships
RelSci Relationships are individuals Ulrich Wandschneider likely has professional access to. A relationship does not necessarily indicate a personal connection.

Managing Director at MediClin GmbH & Co. KG

Relationship likelihood: Strong

Professional at MediClin AG

Relationship likelihood: Strong

Former Chief Financial Officer at ABB Ltd.

Relationship likelihood: Strong

Former Chairman-Management Board & Chief Executive Officer at MediClin AG

Relationship likelihood: Strong

Managing Director at MediClin GmbH & Co. KG

Relationship likelihood: Strong

Professional at MediClin AG

Relationship likelihood: Strong

Professional at MediClin AG

Relationship likelihood: Strong

Chief Executive Officer & Member-Supervisory Board at Vanguard AG

Relationship likelihood: Strong

Professional at M1 Kliniken AG

Relationship likelihood: Strong

Managing Director at Struengmann Family

Relationship likelihood: Strong

Paths to Ulrich Wandschneider
Potential Connections via
Relationship Science
You
Ulrich Wandschneider
Professional at Trilantic Capital Management LP
Education
Undergraduate Degree
Undergraduate Degree
Career History
Professional
Current

Trilantic Capital Management (TCM) seeks opportunities to invest in companies that are looking for equity capital in North America and Western Europe. It targets companies with enterprise value of $100 million to $1 billion in North America and €100 million to €1 billion in Europe. It focuses on business services, consumer, energy and financial services in North America and Consumer & Leisure, TMT, Industrials, Business Services and Healthcare in Europe. It provides financing for management buyouts, recapitalizations, growth equity, corporate divestitures, backing management teams to create new business platforms, generational transitions with investment size of $50 to $250 million in North America and €50 to €150 million in europe. Their strategy is to make control or significant minority equity and equity-oriented investments. It also co-invests with other sponsors. It also takes board seat.

Chief Executive Officer
2004 - ?

MediClin AG engages in the operation of hospitals, rehabilitation clinics, care homes, and medical centers. It operates through the following segments: Post-Acute, Acute, and Other Activities. The Post-Acute segment offers subsequent nursing and curative treatment services. The Acute segment focuses on neurology and neurological early rehabilitation, psychosomatic medicine, psychiatry, orthopedic, and internal medicine. The Other Activities segment refers to nursing care and service business area including software support, controlling activities, quality assurance, and other central services. The company was founded on September 12, 1996 and is headquartered in Offenburg, Germany.

Deputy Chairman of the Supervisory Board
Tenure Unconfirmed

MPH Health Care AG engages in the acquisition and development of companies and shares in companies from the healthcare industry. It focuses on the market of patent-free and patent-protected pharmaceuticals. The company was founded on November 11, 2008 and is headquartered in Berlin, Germany.

Boards & Committees
Member-Supervisory Board
2009 - Current
Chairman, Nomination Committee
2004 - Current
Member-Management Board
Current
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Ulrich Wandschneider. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Ulrich Wandschneider's profile does not indicate a business or promotional relationship of any kind between RelSci and Ulrich Wandschneider.